We are live on ! Find out more
ABPI

Accentia Biopharmaceuticals
ABPI

Delisted

ABPI was delisted on the 3rd of November, 2008.

Back to rankings

Fund managers haven’t disclosed any holdings of ABPI yet.

ABPI Hedge Fund Activity: Q4 2014 in Review

3 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Accentia Biopharmaceuticals (ABPI) for Q4 2014, worth a combined $0 — down 100% from $25 a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ABPI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held Accentia Biopharmaceuticals (ABPI) as of Q4 2014, up from 2 in Q3 2014.
  • Funds reported $0 of Accentia Biopharmaceuticals stock for Q4 2014, down 100% quarter-over-quarter.
  • 1 fund opened new Accentia Biopharmaceuticals positions in Q4 2014 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2014.